News
-
-
PRESS RELEASE
Aumann achieves 17% revenue and 86% EBITDA growth in the first nine months and strengthens growth areas outside the automotive industry
Aumann AG achieves 17% revenue and 86% EBITDA growth in the first nine months of 2024 and focuses on growth areas outside the automotive industry. Read the full quarterly statement at www.aumann.com -
-
-
-
-
-
-
PRESS RELEASE
adesso shows stronger profitability in the third quarter and increases operating result after nine months by 24 % to EUR 66.5 million / Sales revenues grow by 15 % to EUR 961.3 million
adesso SE reports 24% increase in operating result after nine months to EUR 66.5 million, with sales revenues growing by 15% to EUR 961.3 million, driven by strong demand for digitalisation services -
PRESS RELEASE
Dermapharm Holding SE posts strong results for Q3 2024, Arkopharma (France) back above prior-year EBITDA levels for first time
Dermapharm Holding SE reports strong Q3 2024 results with consolidated revenue up 2.7% to EUR 890.1 million. Adjusted EBITDA margin improves. Outlook confirms forecasted targets for 2024
